Life Style Modification Medical and Surgical Management in Patients With Obesity

Recruiting

• Conditions: Weight Change, Body; Obesity; Obesity; Endocrine; Obesity, Metabolically Benign
• Interventions: Procedure: bariatric surgey

• Registration Number: NCT04417582
• Lead Sponsor: Marmara University

Brief Summary

In this is an observational study, obese patients that administed and followed in endocrinology clinic of Marmara University Medical school hospital will follow for clinical and laboratory parameters prospectively for 5 years

Detailed Description

Following available clinical and laboratory parameters will be collected for 5 years Treatment modalities ( life stye modification, medication, bariatric surgery) eating habits quality of life body mass index , blood pressure body fat distribution (impedance measurement) laboratory parameters (serum glucose, OGTT, insülin, lipids,creatinin ,ALT AST,CBC, ferritin calcium, phosphate, Parathormone,25 OH vitamin D, vitamin B12 ,uric acid, albumin, FSH LH testosteron, estrogen ) muscle strength (dynomometer measurement) skin glikolization autoflouresent measurement Bone mineral density mesurements (femur, spine ,forarm)

Study Timeline

• Study Start: 2020-01-01
• Status Verified: 2020-06
• Study First Submitted: 2020-06-02
• Study First Submitted QC: 2020-06-03
• Last Update Submitted: 2020-06-03
• Study First Posted: 2020-06-04
• Last Update Posted: 2020-06-04
• Primary Completion: 2023-12-01
• Study Completion: 2025-12-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

Body mass index over 30 kg/m2 age between 18-65 years

Read More

Exclusion Criteria

active malignancy pregnancy during involvement period chronic inflamatuar diseases

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
life syte modification only	bariatric surgey	obese patients followed with life style modification
medical teatment with antiobesity drugs	bariatric surgey	patients prescribed antiobesity drugs

Primary Outcome Measures

Name	Time	Method
weight loss	6 months interval	%5-10 weight loss
metabolic improvement	6 month	serum lipid levels

Trial Locations

Locations (1)

Marmara University Medical School Section of Endocrinology and Metabolism; 🇹🇷 Istanbul, Turkey